All In Biotech

Drug Trial Radar · NCT00092508

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the Efficacy and Safety of 25 mg QD and 50 mg QD of OPC-6335 Oral Tablets and 800 mg BID of Asacol® in the Maintenance of Ulcerative Colitis Remission

Last checked: Nov 19, 2026Latest source record: Jun 21, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,725 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,725

Planned (sponsor's estimate)

Start

May 2004

Primary completion

Not stated

Study completion May 2007

Sponsor

Sponsor type
Industry
First posted
Sep 28, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This dose comparison study, taking place at over 200 sites worldwide, will compare the dosing, safety and efficacy of an investigational medicine OPC-6535 to the dosing, safety and efficacy of Asacol ® in the maintenance of remission in subjects with ulcerative colitis.

Conditions

  • Ulcerative Colitis

Interventions

  • OPC-6535Drug

  • Asacol®Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Associates

    Huntsville, Alabama

  • West Gastroenterology Medical Group

    Los Angeles, California

  • Mark Lamet

    Hollywood, Florida

  • Borland-Groover Clinic

    Jacksonville, Florida

  • Advanced Gastroenterology Associates

    Palm Harbor, Florida

  • Florida Medical Clinic

    Zephyrhills, Florida

  • Digestive Disorders Associates

    Annapolis, Maryland

  • Metropolitan Gastroenterology Group

    Chevy Cha, Maryland

  • Coastal Research Associates

    Braintree, Massachusetts

  • Clinical Research Institute of Michigan, LLC

    Chesterfield, Michigan

  • Digestive Health Specialists, PA

    Tupelo, Mississippi

  • Center for Digestive and Liver Diseases

    Mexico, Missouri

  • Atlantic Gastroenterology Associates, PA

    Egg Harbor, New Jersey

  • Long Island Clinical Research Associates

    Great Neck, New York

  • Asheville Gastroenterology Associates

    Asheville, North Carolina

  • Charlotte Gastroenterology & Hepatology

    Charlotte, North Carolina

  • Bethany Medical Center

    High Point, North Carolina

  • Hanover Medical Specialists, PA

    Wilmington, North Carolina

  • GI & Liver Consultants

    Dayton, Ohio

  • Sooner Clinical Research

    Oklahoma City, Oklahoma

  • Healthcare Research Consultants

    Tulsa, Oklahoma

  • Medical University of South Carolina

    Charleston, South Carolina

  • Gastroenterology Associates

    Kingsport, Tennessee

  • Gastroenterology Clinic of San Antonio

    San Antonio, Texas

  • Advanced Research Institute

    Ogden, Utah

  • McGuire DVAMC

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.